Karyopharm Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
Karyopharm Therapeutics Inc. (KPTI) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 1.96 million shares for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2019-02-28
- Karyopharm Therapeutics Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2018 was 1.96M shares, a 0.00% change from fiscal 2017.
- Karyopharm Therapeutics Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2017 was 1.96M shares, a 0.00% change from fiscal 2016.
- Karyopharm Therapeutics Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2016 was 1.96M shares, a 0.00% change from fiscal 2015.
- Karyopharm Therapeutics Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2015 was 1.96M shares, a 0.00% change from fiscal 2014.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month |
|---|---|
| 2018-12-31 | 1.96M shares 10-K · filed 2019-02-28 |
| 2017-12-31 | 1.96M shares 10-K · filed 2018-03-15 |
| 2016-12-31 | 1.96M shares 10-K · filed 2017-03-16 |
| 2015-12-31 | 1.96M shares 10-K · filed 2016-03-15 |
| 2014-12-31 | 1.96M shares 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |